Press Coverage, continued
The vast majority of oncologists (84%) say that they consider costs to the patient when recommending cancer treatments. But fewer than half frequently discuss cost issues with their patients. These are some of the results of a national survey conducted by Peter Neuman, ScD (Tufts Medical Center) and CBDSM's Peter A. Ubel, MD, funded by the California HealthCare Foundation. Results were published in the January 2010 Health Affairs. Ubel comments: "Oncologists understand, from up close, that cancer diagnoses and treatment leave many people bankrupt. They want to do what is medically right for their patients, but they are struggling to figure out what, at the same time, is economically right for them." Several CBDSM faculty contributed to an article by lead author Monica Morrow, MD, that appeared recently in the Journal of the American Medical Association. The authors investigated the concern that mastectomy is overused in the US. In surveying 1,984 patients, they found that 75% had breast-conserving surgery as their initial surgical therapy. Of these, 38% required additional surgery. Although breast-conserving surgery was recommended by surgeons and attempted in the majority of patients evaluated, the mastectomy rate was affected by surgeon recommendation, patient decision, and failure of breast-conserving surgery. CBDSM authors on this article were Reshma Jagsi, MD, DPhil; Amy K. Alderman, MD; Jennifer J. Griggs, MD, MPH; and Sarah T. Hawley, PhD. Other authors included Ann A. Hamilton, John J. Graff, and Steven J. Katz. Read the article at http://jama.amaassn.org/content/vol302/issue14/index.dtl 
